Senior Director, CMC Technical Development
Core
Lead strategic and technical development for Amylyx's clinical and late-stage pipeline (synthetic peptide, antisense oligonucleotide, small molecule), ensuring phase-appropriate process development, scale-up, and regulatory readiness.
Role type
Senior Director, CMC Technical Development
Builds
Clinical and late-stage drug substance and drug product processes for regulatory filing and commercial launch
Domain
Biotechnology / Pharmaceutical Manufacturing (CMC)
Required skills
Strategic leadership, drug substance and drug product process development, formulation selection, process scale-up, validation readiness, CDMO management, regulatory submission support, Quality by Design (QbD), global CMC guidance knowledge, technical troubleshooting, team mentorship
Preferred skills
Experience with small molecule, synthetic peptide, oligonucleotide, RNA, and/or amino acid chemistries, track record of successful product approvals, ability to influence without direct authority
Technologies
cGMP, FDA/EMA/ICH regulatory frameworks, GMP campaigns
Responsibilities
Lead technical development across the pipeline ensuring alignment with clinical and business objectives; Provide technical requirements, risks, and timelines for CMC asset teams; Partner with CMC Strategy to integrate technical plans into asset strategies; Identify critical path activities and develop mitigation plans; Lead CDMO evaluation, selection, onboarding, and technology transfer; Travel to global sites for technical transfers and troubleshooting; Lead drug substance and drug product development including formulation and process optimization; Establish scalable manufacturing processes and control strategies; Support regulatory submissions (INDs, NDAs, BLAs) with technical content; Lead, mentor, and develop internal technical development team members; Allocate resources and build scalable technical development processes
Seniority
Senior Director, strategic leadership with hands-on technical contribution